7 unknown. 7 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 7 |
| Phase 2 | 5 | Unknown 5 |
Follow pomalidomide: new trials by email Literature Review of pomalidomide trials Research Report on pomalidomide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Bioequivalence Study of Pomalidomide Pomalidomide 4 MG Oral Capsule - Bioequivalence Study | Phase 1 | Unknown | Megalabs | 10 | 2024-09-15 | 2023-09-28 |
| The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma Pomalidomide, Bendamustine, Dexamethasone - Relapsed, Refractory, Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 56 | 2021-02-01 | 2021-02-21 |
| Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma Lenalidomide or Pomalidomide, REOLYSIN - Multiple Myeloma | Phase 1 | Unknown | University of Leeds | 4 | 2017-06-05 | 2020-01-22 |
| Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma pomalidomide, ixazomib, dexamethasone - Multiple Myeloma in Relapse | Phase 1 / Phase 2 | Unknown | Alliance for Clinical Trials in Oncology | 118 | 2014-02-01 | 2023-12-01 |
| Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma Bendamustine, Pomalidomide, Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Cristina Gasparetto | 56 | 2013-01-07 | 2024-02-20 |
| Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma TH-302, TH-302 and Dexamethasone, TH-302 Dose Escalation and Dexamethasone in Combination with Bortezomib - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Threshold Pharmaceuticals | 98 | 2012-02-01 | 2016-06-02 |
| Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma Pomalidomide, Pegylated Liposomal Doxorubicin (PLD), Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Unknown | Oncotherapeutics | 70 | 2012-02-01 | 2016-03-10 |
Multiple Myeloma (5) · Hypoxia (1) · Neoplasms, Plasma Cell (1) · Recurrence (1)
Alliance for Clinical Trials in Oncology (1) · Cristina Gasparetto (1) · Megalabs (1) · Oncotherapeutics (1) · Sun Yat-sen University (1) · Threshold Pharmaceuticals (1) · University of Leeds (1)
United States (4) · China (1) · India (1) · United Kingdom (1)
Gordon Cook (1) · Gwynn Long, MD (1) · James R Berenson, MD (1) · M. Gowtham, MD (1) · Peter Voorhees, MD (1)
U10CA031946 (1)